使用 Gα12/13 G 蛋白质嵌合体重定向 GPR56 信号
Felix Faas1, Amalie Nørskov2, Peter J Holst1,3
1Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
Basic & clinical pharmacology & toxicology
|August 25, 2023
概括
研究人员开发了新的仿制G蛋白来检测粘附G蛋白结合受体 (aGPCRs) 的信号,特别是GPR56,克服了研究这些重要药物标的挑战.
科学领域:
- 分子药理学分子药理学
- 与G蛋白结合的受体信号传递
背景情况:
- 粘附G蛋白结合受体 (aGPCRs) 是一个主要的GPCR亚类,但缺乏经过临床批准的药物.
- 一种aGPCR的GPR56/ADGRG1与多微症和癌症有关,使其成为一个关键的治疗点.
- 由于没有直接的第二信使读数,研究Gα12/13信号,这种信号在GPR56等aGPCR中很常见,很困难.
研究的目的:
- 设计一种方法来检测来自aGPCRs的Gα12/13信号.
- 验证使用嵌合式G蛋白来将Gα12/13活动转化为可测量的信号.
- 评估这些工具在药物发现和aGPCR研究方面的潜力.
主要方法:
- 开发 Gαq 嵌合蛋白 (GαΔ6q12myr 和 GαΔ6q13myr) 来配对 Gα12/13 到 Gαq 信号通路.
- 利用转录因子 luciferase 记者系统来检测 GPR56 信号.
- 进行了异醇-3-酸盐测定,以测量第二代信使.
主要成果:
- 化学G蛋白成功地将GPR56的基底和联体增强的Gα12/13信号转化为Gαq介导的读数.
- 联体P7和P19被证明可以通过嵌合体系统增强GPR56的信号传输.
- 直接影响第二代信使被证明使用inositol-3-phosphate测定.
结论:
- 工程化学G蛋白提供了一种可行的方法来研究像GPR56.6这样的aGPCR中的Gα12/13信号传递.
- 这些工具可以促进功能研究,药物查,以及其他aGPCRs的脱化.
- 这种方法克服了GPCR药理学和药物开发中的一个重大障碍.
相关概念视频
Activation and Inactivation of G Proteins
7.3K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
7.3K
IP3/DAG Signaling Pathway
12.2K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.2K
G-protein Coupled Receptors
120.2K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
120.2K
G Protein-coupled Receptors
12.2K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
12.2K
GPCR Desensitization
6.1K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.1K
Transducer Mechanism: G Protein–Coupled Receptors
2.1K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.1K


